- Home
- ELBM vs EDSA Comparison
ELBM vs EDSA Comparison
Compare ELBM & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELBM | EDSA |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.9M | 56.1M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ELBM | EDSA |
|---|---|---|
| Price | $0.51 | $5.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.15 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 302.6K | 59.3K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $0.72 |
| 52 Week High | $8.70 | $20.32 |
Technical Indicators
Market Signals| Indicator | ELBM | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 32.29 |
| Support Level | $0.50 | $4.87 |
| Resistance Level | $0.60 | $6.58 |
| Average True Range (ATR) | 0.03 | 0.52 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 7.67 | 9.85 |
Price Performance
Historical ComparisonAbout ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry. The Company's operating segments are Refinery, Exploration and Evaluation, Corporate and Other.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.